Zarema E. Gilazieva

Zarema E. Gilazieva

Auto-generated profile, based on publicly available information

Zarema E. Gilazieva

Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2024 in Exploration of Targeted Anti-tumor Therapy
Verified
Journal Article
Open access
PDF file
VPVladislava V. Pipiya
Vladislava V. Pipiya
ZGZarema E. Gilazieva
Zarema E. Gilazieva
SIShaza S. Issa
Shaza S. Issa
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov
VSValeriya Solovyeva
Valeriya Solovyeva
Passaged cell lines represent currently an integral component in various studies of malignant neoplasms. These cell lines are utilized for drug screening both in monolayer cultures or as part of three-dimensional (3D) tumor models. They can also be used to model the tumor microenvironment in vitro and in vivo through xenotransplantation into immunocompromised animals. However, immortalized cell lines have some limitations of their own. The homogeneity of cell line populations and the extensive passaging in monolayer systems make these models distant from the original disease. Recently, there has been a growing interest among scientists in the use of primary cell lines, as these are passaged directly from human tumor tissues. In this case, cells retain the morphological and functional characteristics of the tissue from which they were derived, an advantage often not observed in passaged cultures. This review highlights the advantages and limitations of passaged and primary cell cultures, their similarities and differences, as well as existing test systems that are based on primary and passaged cell cultures for drug screening purposes.